1. Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. (14th May 2012) Authors: Engebraaten, Olav; Edvardsen, Hege; Løkkevik, Erik; Naume, Bjørn; Kristensen, Vessela; Ottestad, Lars; Natarajan, Vasanti Other Names: Garcia-Lora A. M. Academic Editor.; Nicco C. Academic Editor. Journal: ISRN oncology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗